Medical AI Decision Thresholds: Turning Model Scores into Reviewable Operating Points

A medical AI model may output a probability-like score, a similarity value, or a continuous measure of confidence. A workflow still needs a rule for what happens next.

Should a case be prioritized, sent for a second review, marked negative, deferred, or escalated for more evidence? The score alone does not answer that question. The answer comes from an operating point: a threshold or set of thresholds connected to a defined intended use, population, error trade-off, and human process.

This distinction matters because a technically strong model can perform poorly at the selected operating point. It can rank cases well while producing too many false alerts, missing too many important cases, or overwhelming the available review team. A reviewable threshold process makes those consequences explicit before protected evaluation and before a score is allowed to drive action.

A model score is not yet a decision

A score orders or separates cases according to what the model learned. A threshold converts that score into a state such as positive, negative, review, or defer.

That conversion is a policy choice. It depends on questions the model cannot answer by itself:

• What action follows each state?
• What is the consequence of a false negative?
• What is the cost and workload of a false positive?
• Is a qualified reviewer available for uncertain cases?
• How quickly must the decision be made?
• Which population and setting does the policy cover?

A threshold that is acceptable for retrospective research may be unusable in a queue with limited specialist capacity. A threshold designed for prioritization may be inappropriate for excluding disease. The same model can therefore require different operating policies for different intended uses, but those policies must not be mixed or described as interchangeable.

Define the intended action before selecting the threshold

Threshold selection should begin with a workflow statement, not with a preferred metric.

Specify the user, population, input, output, setting, and action. Then define what each possible model state means. For example, a bounded review workflow might use two thresholds:

1. a high-priority state that moves a case forward in the queue,
2. a routine state that preserves normal review,
3. and an intermediate uncertainty band that requests another reader or more evidence.

This is not automatically safer than one threshold. It is useful only if every state has an owner, a response time, and a documented fallback. An abstention bucket with nobody assigned to it simply hides unresolved work.

The ground-truth and reference-standard process also has to match the action. If the model is meant to prioritize a clinical review, the target label, follow-up window, and decision unit should support that question rather than a loosely related proxy.

Separate discrimination, calibration, and classification

Three ideas are often collapsed into one:

• Discrimination asks whether higher-risk cases tend to receive higher scores than lower-risk cases.
• Calibration asks whether predicted risks correspond to observed frequencies in a defined population and context.
• Classification at an operating point asks what sensitivity, specificity, predictive values, alert volume, and error pattern result after a threshold is applied.

A model can discriminate well and still be poorly calibrated.[1] It can also be calibrated on average while performing inadequately at the threshold that matters for the workflow. None of these properties substitutes for the others.

This is why a raw neural-network output should not be presented as a clinical probability without supporting calibration evidence. It is also why an AUROC does not choose an operating point. AUROC summarizes ranking across thresholds; the workflow still needs a documented policy at one or more selected points.

For a broader metric foundation, see Medical AI Model Evaluation Beyond Accuracy.

Select on development or validation evidence, not the protected test

Teams commonly inspect a final test result, move the threshold until the confusion matrix looks better, and then report the adjusted result as if it were independent. That turns the test cohort into development data.

A more defensible sequence is:

1. define the intended use and candidate threshold-selection rule,
2. fit the model and any calibration transformation using permitted development data,
3. compare candidate operating points on validation evidence,
4. choose the operating point using predeclared technical and workflow criteria,
5. freeze the model, preprocessing, calibration, threshold, and analysis code,
6. evaluate that locked package on protected data.

The exact data architecture can vary, but the principle is stable: protected outcomes should estimate performance after the decision policy is fixed. If the outcome causes the policy to change, the strength of the evaluation claim changes too.

This belongs alongside leakage-safe train, validation, and test splits. Split integrity covers more than rows in folders. It covers every choice influenced by outcomes, including the operating threshold.

Quantify consequences at candidate operating points

Sensitivity and specificity are necessary, but a workflow also needs counts and capacity.

For each candidate threshold, examine:

• true positives, false positives, true negatives, and false negatives,
• positive and negative predictive values at the evaluated prevalence,
• cases sent to manual review,
• expected reviews per day or week,
• turnaround-time implications,
• errors by site, device, subgroup, and input-quality stratum,
• confidence intervals and instability across resamples where appropriate.

A threshold that improves sensitivity may also increase false-alert volume. Whether that trade-off is acceptable depends on the consequence of a missed case, the burden of additional review, and the next action. Decision-curve analysis is one framework for connecting threshold preferences to net benefit, but it does not remove the need for clinical and operational judgment.[2]

Absolute counts are particularly important. A small percentage can still create an unmanageable queue at production volume. Conversely, a seemingly modest sensitivity gain may matter when the missed cases carry high consequence. The decision should be tied to the real workflow, not optimized for a visually attractive metric.

Treat uncertainty and escalation as designed states

Not every case should be forced through one binary boundary.

Uncertainty can come from poor input quality, missing context, disagreement in the reference standard, distance from the development distribution, or a score near the operating point. These are different conditions and may deserve different responses.

A reviewable policy can define:

• a quality-control rejection before inference,
• a low-confidence or indeterminate band,
• a route to a qualified second reader,
• a request for another modality or source of evidence,
• a stop-use condition when inputs fall outside scope.

The human role must remain concrete. Human-in-the-loop workflows are not created merely by adding an approval button. Teams need ownership, escalation criteria, audit states, and a way to measure overrides and unresolved cases. WHO guidance similarly emphasizes accountability and human responsibility in health AI governance.[4]

Freeze a complete operating-point contract

A threshold value without context is not reproducible evidence.

The frozen record should identify:

• model and checkpoint version,
• preprocessing and input-quality rules,
• score definition and class orientation,
• calibration method and fitting cohort,
• threshold value or threshold-selection rule,
• validation cohort and reference-standard version,
• metrics, confidence intervals, and subgroup checks,
• intended user, action, exclusions, and fallback,
• code and configuration versions,
• approval owner and effective date.

This contract prevents a subtle failure mode: two systems can use the same model weights but produce different actions because preprocessing, score orientation, calibration, or threshold configuration differs.

Transparent reporting helps reviewers understand what was actually evaluated. TRIPOD+AI provides a reporting framework for prediction models using regression or machine-learning methods and reinforces the need to describe intended use, methods, and evaluation clearly.[3]

Re-check transportability without silently retuning

An operating point selected at one site may behave differently elsewhere because prevalence, acquisition, case mix, workflow, and reference standards differ. Calibration can also change across populations and time.[1]

External evaluation should first measure the locked policy as transported. If performance is unsuitable, teams can investigate recalibration, threshold revision, or scope restriction, but that is a new development decision. The external test cohort should not quietly become the source of an improved threshold while still being described as untouched validation.

The same distinction applies across devices and populations. See External Validation for Medical AI for the broader transportability workflow.

Monitor the operating point after release

A threshold is not a permanent fact. Input conditions, prevalence, reviewer capacity, and downstream actions can change.

Monitoring can track:

• score distributions and input-quality failures,
• alert and abstention rates,
• manual-review volume and turnaround time,
• overrides and escalation outcomes,
• delayed outcome-linked sensitivity and false-alert burden,
• subgroup and site-specific degradation,
• changes in prevalence or reference-standard practice.

A change in alert volume does not by itself prove model drift. It is a signal to investigate data, workflow, software, population, and label changes. The response should follow a controlled process. Retuning a threshold on recent failures without a new validation plan can trade one visible problem for an unmeasured one.

This is why model monitoring in regulated workflows should include the decision policy, not only model uptime and input drift.

A practical threshold review record

Before a score controls workflow, reviewers should be able to answer:

1. What action and population does the operating point cover?
2. Which errors matter most, and who approved the trade-off?
3. Was the score calibrated for the stated interpretation?
4. Which data selected the model, calibration, and threshold?
5. Was the protected evaluation untouched until the full contract was frozen?
6. What sensitivity, specificity, predictive values, counts, and workload result?
7. Which subgroups, sites, devices, and quality strata were checked?
8. What happens to uncertain, ungradable, or out-of-scope cases?
9. Which artifact versions reproduce the result?
10. What monitoring signal triggers review, restriction, recalibration, or retirement?

MAEA is designed to support linked experiment, artifact, dataset, and evidence records across this lifecycle. The platform can help keep the operating-point contract inspectable, but the clinical, statistical, quality, and workflow decisions remain the responsibility of qualified teams.

A medical AI threshold is therefore not a magic number hidden in a metric report. It is a reviewable bridge between model evidence and human action. Treating it as a governed, versioned policy makes both the technical result and the workflow claim easier to inspect.

References

1. Van Calster et al., Calibration: the Achilles heel of predictive analytics
2. Vickers and Elkin, Decision curve analysis: a novel method for evaluating prediction models
3. Collins et al., TRIPOD+AI statement
4. World Health Organization, Ethics and governance of artificial intelligence for health